CC vs OLN
As of Sep 20, 2026, Chemours (CC) scores 1.5/10 and OLIN Corp (OLN) 2.3/10 on AlphaStocks' five-model composite, so OLN scores higher. CC trades 26% below its model fair value.
CC
Chemours Co
1.5
Avoid
$14.33
OLN
OLIN Corp
2.3
Avoid
$16.83
CC vs OLN: Which is the Better Investment?
Chemours Co (CC) scores 1.5/10 while OLIN Corp (OLN) scores 2.3/10 on AlphaStocks' composite model. OLIN Corp has the higher composite rating of Avoid.
This comparison is algorithmically generated and is not financial advice.
| Metric | CC | OLN |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 1.5/10 | 2.3/10▲ |
| Rating | Avoid | Avoid▲ |
| Price | $14.33 | $16.83 |
| P/E Ratio | — | — |
| ROE | -140.9% | -4.9%▲ |
| Market Cap | $2B | $2B |
| Fair Value | $19.24 | — |
| Dividend Yield | 2.9% | 3.9%▲ |
| Sector Rank | #76 of 78 | #69 of 78▲ |
| Model Verdicts | ||
| Piotroski | Neutral | Neutral |
| Buffett | Caution | Neutral▲ |
| Graham | Caution | Neutral▲ |
| Lynch | Caution | Neutral▲ |
| Greenblatt | Caution | Caution |
Related comparisons
CC vs OLN: Which Stock Scores Higher?
Chemours Co (CC) and OLIN Corp (OLN) are both in the Materials sector. OLN currently leads with a composite score of 2.3/10 (Avoid) compared to CC's 1.5/10 (Avoid).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer